Advertisement

Topics

Phase 1 Trial Finds Single Dose of PAH Drug as Effective as Twice-Daily Formulation

10:07 EDT 29 Jun 2017 | PharmPro

Arena Pharmaceuticals completes trial comparing once-daily, extended release formulation of ralinepag with twice-daily, immediate release formulation in normal healthy volunteers.
Contributed Author: 
PR Newswire

Original Article: Phase 1 Trial Finds Single Dose of PAH Drug as Effective as Twice-Daily Formulation

NEXT ARTICLE

More From BioPortfolio on "Phase 1 Trial Finds Single Dose of PAH Drug as Effective as Twice-Daily Formulation"

Advertisement
Quick Search
Advertisement
Advertisement